A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

NCT04884997 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: toripalimab
DRUG: Temozolomide Injection

Sponsor

First Affiliated Hospital of Zhejiang University